These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 21250497)
1. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma]. Szturz P; Adam Z; Rehák Z; Koukalová R; Kodet R; Nebeský T; Neubauer J; Moulis M; Smardová L; Mayer J Vnitr Lek; 2010 Nov; 56(11):1177-93. PubMed ID: 21250497 [TBL] [Abstract][Full Text] [Related]
2. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation]. Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704 [TBL] [Abstract][Full Text] [Related]
3. [Pulmonary Langerhans cell histiocytosis--evaluation of the disease activity and treatment response using PET-CT (SUV(max) Pulmo/SUV(max) Hepar index). Description of own experience and literature review]. Adam Z; Rehák Z; Koukalová R; Szturz P; Nebeský T; Neubauer J; Krejcí M; Pour L; Hanke I; Doubková M; Merta Z; Hájek R; Mayer J Vnitr Lek; 2010 Dec; 56(12):1228-50. PubMed ID: 21261110 [TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
5. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis]. Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832 [TBL] [Abstract][Full Text] [Related]
6. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms]. Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680 [TBL] [Abstract][Full Text] [Related]
7. [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation]. Adam Z; Veselý K; Krejcí M; Pour L; Fakan F; Soumarová R; Neubauer J; Vanícek J; Cerný J; Kren L; Bolcák K; Smardová L; Hájek R; Mayer J Vnitr Lek; 2009 Feb; 55(2):147-57. PubMed ID: 19348397 [TBL] [Abstract][Full Text] [Related]
8. Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693 [TBL] [Abstract][Full Text] [Related]
9. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients]. Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165 [TBL] [Abstract][Full Text] [Related]
11. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine]. Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
14. Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma. Szturz P; Řehák Z; Koukalová R; Adam Z; Krejčí M; Pour L; Zahradová L; Vaníček J; Nebeský T; Hájek R; Mayer J Nucl Med Biol; 2012 Apr; 39(3):429-36. PubMed ID: 22172385 [TBL] [Abstract][Full Text] [Related]
15. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review]. Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585 [TBL] [Abstract][Full Text] [Related]
16. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071 [TBL] [Abstract][Full Text] [Related]
18. Multifocal soft tissue Langerhans' cell histiocytosis treated with PET-CT based conformal radiotherapy. Onal C; Oymak E; Reyhan M; Canpolat T; Ozyilkan O Jpn J Radiol; 2015 Sep; 33(9):603-6. PubMed ID: 26211006 [TBL] [Abstract][Full Text] [Related]
19. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis. Lee HJ; Ahn BC; Lee SW; Lee J Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842 [TBL] [Abstract][Full Text] [Related]